Isoform-Specific Effects of Apolipoprotein E on Atherogenesis
Hiroaki Yoshida, Sergio Fazio(Alzheimer's Association), Vladimir R. Babaev(Vanderbilt University Medical Center), Linda A. Gleaves(Pulmonary and Allergy Associates), Alyssa H. Hasty(Vanderbilt University), Hiroyuki Ishiguro(Washington University in St. Louis), MacRae F. Linton(Vanderbilt University), Amy S. Major(Vanderbilt University Medical Center), Yan Ru Su(Vanderbilt University)
Cited by 25
Related Papers
Current Perspectives on Statins
|Circulation|2000|1.2k
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
|Nature|2007|732
Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis
|Nature Medicine|2001|692
Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis
|Nature Medicine|2009|482
Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis
|American Journal of Physiology-Lung Cellular and Molecular Physiology|2010|311